Are you 50 or older and in good general health? If you’ve had a pneumonia shot in the past (like Prevnar® or Pneumovax®), you may be able to help with our new research study.
Pneumococcal Vaccine Study
Age Range:
50 to 100
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This research study is evaluating an investigational 31-valent pneumococcal conjugate vaccine (VAX-31). The purpose is to learn more about the safety of the vaccine and how the body’s immune system responds to it in adults who have already been vaccinated against pneumonia in the past.
Qualifications
Qualifications You may be able to join if you:
- Are 50 years of age or older
- Are in good general health without any unstable medical conditions
- Have previously received a licensed pneumonia vaccine (such as Prevnar® or Pneumovax®)
- Had your most recent pneumonia vaccination at least 12 months ago
Note: If your most recent vaccine was PCV21 (Capvaxive™), you may qualify if it was received at least 6 months ago.
FEATURED STUDIES
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]
Are you 50 or older and in good general health? If you’ve had a pneumonia shot in the past (like Prevnar® or Pneumovax®), you […]